SEC Form 4 · accession 0001567619-19-005895

Cimarex Resolute LLC · REN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

Monarch Alternative Capital LP

Director · Other

Monarch GP LLC

Director · Other

MDRA GP LP

Director · Other

Period of report

Mar 1, 2019

Accepted (ET)

Mar 4, 2019 · 11:03 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001469510

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	D/I	Nature of ownership
Common Stock, par value $0.0001 per share ("Common Stock")^F1,F2,F3	Mar 1, 2019	D	1	—	D	I	See footnotes
Common Stock^F1,F4	Mar 1, 2019	D	2,770	—	D	D
Common Stock^F1,F2,F5	Mar 1, 2019	D	70,868	—	D	I	See footnotes
Common Stock^F1,F2,F6	Mar 1, 2019	D	543,931	—	D	I	See footnotes
Common Stock^F1,F2,F7	Mar 1, 2019	D	452,297	—	D	I	See footnotes
Common Stock^F1,F2,F8	Mar 1, 2019	D	862,721	—	D	I	See footnotes
Common Stock^F1,F2,F9	Mar 1, 2019	D	338,254	—	D	I	See footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1See Exhibit 99.1
F2See Exhibit 99.1
F3See Exhibit 99.1
F4See Exhibit 99.1
F5See Exhibit 99.1
F6See Exhibit 99.1
F7See Exhibit 99.1
F8See Exhibit 99.1
F9See Exhibit 99.1

Remarks

Joseph Citarrella, a Managing Principal of Monarch Alternative Capital LP, served on the board of directors of the Issuer as a representative of Monarch Alternative Capital LP. As a result, each of Monarch Alternative Capital LP, and by virtue of their control of Monarch Alternative Capital LP, MDRA GP LP and Monarch GP LLC is a "director-by-deputization" solely for purposes of Section 16 of the Exchange Act. Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filers' Information and Signatures